AMGEN Inc. (NASDAQ:AMGN) currently has a daily average trading volume of 3.00M but it saw 1668742 shares traded in last market. With a market cap of 147.07B USD, the company’s current market price of $274.42 came falling about -0.65 while comparing to the previous closing price of $276.21. In past 52 weeks, the stock remained buoying in the range of price level as high as $329.72 and as low as $211.71.
Taking a look at 20-day trading activity of AMGEN Inc. (AMGN) gives us an average price of $276.36, while its current price level is -16.77% below from 52-week high level whereas it is 29.62% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $288.32 while that of 200 days or SMA-200 reads an average of $269.12. A closer look into the stock’s movement over the week reveals that its volatility is standing at 1.73% during that period while stretching the period over a month that increases to 1.73%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 42.06 which implies that the stock is in neutral territory.
Leerink Partners downgraded its recommendation for the stock as a “Market Perform” from “Outperform” on February 07, 2024 while assigning a price target range of $324-$318. Daiwa Securities issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $264 and $320.
Over the week, AMGN’s stock price is moving -2.61% down while it is -1.78% when we observe its performance for the past one month. Year-to-date it is -4.72% down and over the past year, the stock is showing an upside performance of 13.51%.
The latest quarterly earnings report issued by the company was for quarter ended 12/30/2023, when its quarterly earnings per share (EPS) of $4.71 beat the consensus estimate of $4.6 for the same. For AMGN, analysts are forecasting an EPS-growth rate of 4.90% for current year and estimate for EPS growth in next year is 8.10%. In next quarter, company is expected to be making quarterly sales of $8.33 billion as analysts are expecting the sales for current fiscal year at $33.03 billion and seeing the company making $34.16 billion in sales next year. Moreover, analysts are in estimates of $7.54 billion for current-quarter revenue.
Currently, AMGEN Inc.’s total number of outstanding shares is 535.40M with 0.25% of that held by the insiders while 80.87% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 9.58% and return on equity (ROE) at 135.79%. It has a price to earnings ratio (P/E ratio) of 21.98 while having a 13.03 of forward P/E ratio. Stock’s beta reads 0.60. Stock has a price to book (P/B) ratio of 23.58 while price to sale or P/S ratio amounts to 5.25. Its return on asset (ROA) is 8.28% on average.
